Vitrolife AB Statistics
Total Valuation
Vitrolife AB has a market cap or net worth of SEK 20.06 billion. The enterprise value is 21.13 billion.
Market Cap | 20.06B |
Enterprise Value | 21.13B |
Important Dates
The last earnings date was Thursday, July 17, 2025.
Earnings Date | Jul 17, 2025 |
Ex-Dividend Date | Apr 30, 2025 |
Share Statistics
Vitrolife AB has 135.42 million shares outstanding. The number of shares has increased by 0.10% in one year.
Current Share Class | 135.42M |
Shares Outstanding | 135.42M |
Shares Change (YoY) | +0.10% |
Shares Change (QoQ) | n/a |
Owned by Insiders (%) | 0.03% |
Owned by Institutions (%) | 64.25% |
Float | 75.04M |
Valuation Ratios
The trailing PE ratio is 44.20 and the forward PE ratio is 34.09. Vitrolife AB's PEG ratio is 2.86.
PE Ratio | 44.20 |
Forward PE | 34.09 |
PS Ratio | 5.66 |
PB Ratio | 1.51 |
P/TBV Ratio | n/a |
P/FCF Ratio | 37.21 |
P/OCF Ratio | 28.94 |
PEG Ratio | 2.86 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 18.83, with an EV/FCF ratio of 39.20.
EV / Earnings | 46.44 |
EV / Sales | 5.97 |
EV / EBITDA | 18.83 |
EV / EBIT | 30.40 |
EV / FCF | 39.20 |
Financial Position
The company has a current ratio of 3.41, with a Debt / Equity ratio of 0.15.
Current Ratio | 3.41 |
Quick Ratio | 2.61 |
Debt / Equity | 0.15 |
Debt / EBITDA | 1.78 |
Debt / FCF | 3.70 |
Interest Coverage | 7.09 |
Financial Efficiency
Return on equity (ROE) is 3.45% and return on invested capital (ROIC) is 2.85%.
Return on Equity (ROE) | 3.45% |
Return on Assets (ROA) | 2.58% |
Return on Invested Capital (ROIC) | 2.85% |
Return on Capital Employed (ROCE) | 4.29% |
Revenue Per Employee | 3.09M |
Profits Per Employee | 396,687 |
Employee Count | 1,169 |
Asset Turnover | 0.21 |
Inventory Turnover | 3.63 |
Taxes
In the past 12 months, Vitrolife AB has paid 156.00 million in taxes.
Income Tax | 156.00M |
Effective Tax Rate | 25.53% |
Stock Price Statistics
The stock price has decreased by -36.44% in the last 52 weeks. The beta is 1.79, so Vitrolife AB's price volatility has been higher than the market average.
Beta (5Y) | 1.79 |
52-Week Price Change | -36.44% |
50-Day Moving Average | 147.39 |
200-Day Moving Average | 187.97 |
Relative Strength Index (RSI) | 54.75 |
Average Volume (20 Days) | 134,344 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Vitrolife AB had revenue of SEK 3.54 billion and earned 455.00 million in profits. Earnings per share was 3.35.
Revenue | 3.54B |
Gross Profit | 2.08B |
Operating Income | 695.00M |
Pretax Income | 611.00M |
Net Income | 455.00M |
EBITDA | 1.07B |
EBIT | 695.00M |
Earnings Per Share (EPS) | 3.35 |
Balance Sheet
The company has 921.00 million in cash and 1.99 billion in debt, giving a net cash position of -1.07 billion or -7.92 per share.
Cash & Cash Equivalents | 921.00M |
Total Debt | 1.99B |
Net Cash | -1.07B |
Net Cash Per Share | -7.92 |
Equity (Book Value) | 13.28B |
Book Value Per Share | 98.07 |
Working Capital | 1.54B |
Cash Flow
In the last 12 months, operating cash flow was 693.00 million and capital expenditures -154.00 million, giving a free cash flow of 539.00 million.
Operating Cash Flow | 693.00M |
Capital Expenditures | -154.00M |
Free Cash Flow | 539.00M |
FCF Per Share | 3.98 |
Margins
Gross margin is 58.85%, with operating and profit margins of 19.63% and 12.85%.
Gross Margin | 58.85% |
Operating Margin | 19.63% |
Pretax Margin | 17.26% |
Profit Margin | 12.85% |
EBITDA Margin | 30.30% |
EBIT Margin | 19.63% |
FCF Margin | 15.22% |
Dividends & Yields
This stock pays an annual dividend of 1.10, which amounts to a dividend yield of 0.74%.
Dividend Per Share | 1.10 |
Dividend Yield | 0.74% |
Dividend Growth (YoY) | 10.00% |
Years of Dividend Growth | 2 |
Payout Ratio | 32.83% |
Buyback Yield | -0.10% |
Shareholder Yield | 0.64% |
Earnings Yield | 2.27% |
FCF Yield | 2.69% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | |
Lynch Upside | |
Graham Number | |
Graham Upside |
Stock Splits
The last stock split was on May 17, 2018. It was a forward split with a ratio of 5.
Last Split Date | May 17, 2018 |
Split Type | Forward |
Split Ratio | 5 |
Scores
Vitrolife AB has an Altman Z-Score of 4.9 and a Piotroski F-Score of 8.
Altman Z-Score | 4.9 |
Piotroski F-Score | 8 |